All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Giant Cell Carcinoma | NCIT_C3779 | [A malignant epithelial neoplasm composed of giant, pleomorphic cells.] |
| Propoxyphene Napsylate | NCIT_C29386 | [A synthetic diphenyl propionate derivative structurally related to methadone, Propoxyphene Napsylate acts as a central narcotic and analgesic agent by interaction with mu opioid receptors, but with less selectivity then morphine. The dextro-isomer has analgesic effect, while the levo-isomer exerts an antitussive effect. The napsylate salt allows better dosage formulation than the hydrochloride salt. (NCI04)] |
| Propoxyphene Napsylate/Acetaminophen | NCIT_C29387 | [A combination preparation of propoxyphene napsylate and acetaminophen, with analgesic and antipyretic activities. Propoxyphene napsylate is a mild narcotic analgesic that binds to mu-opioid receptors in the central nervous system (CNS), thereby mimicking the effect of endogenous opioids. Acetaminophen possesses analgesic and antipyretic effects by interfering with prostaglandin synthesis.] |
| Propylene Glycol | NCIT_C29388 | [A propanediol that exists as a clear, colorless and hygroscopic liquid and consists of propane where the hydrogens at positions 1 and 2 are substituted by hydroxyl groups. Propylene glycol is used as an organic solvent and diluent in pharmaceuticals and many other industrial applications.] |
| Non-Aerosol Spray Dosage Form | NCIT_C68941 | [A spray composed of active and/or inert ingredient(s) that are expelled from a delivery device without the use of a propellant.] |
| Prophyllin CCC | NCIT_C29389 | [A topical emollient ointment, by Rystan Company, containing sodium propionate and chlorophyllin copper complex. Chlorophyllin copper complex deodorizes the skin whereas sodium propionate has antifungal activity.] |
| Aerosol Foam with Applicator | NCIT_C68942 | |
| Capsule 12 Hour Sustained Release Dosage Form | NCIT_C68943 | [A capsule designed to release active and/or inert ingredient(s) slowly so as to achieve a constant circulating concentration of the ingredient over a 12 hour time interval.] |
| Capsule 24 Hour Sustained Release Dosage Form | NCIT_C68944 | [A capsule designed to release active and/or inert ingredient(s) slowly so as to achieve a constant circulating concentration of the ingredient over a 24 hour time interval.] |
| Enteric Coated Capsule Dosage Form | NCIT_C68945 | [A capsule covered with a substance that is designed to delay the release of active and/or inert ingredient(s) until the capsule passes into the intestines.] |
| Delayed Release Capsule Dosage Form | NCIT_C42902 | [A capsule covered with a substance that is designed to impede the immediate release of the active and/or inert ingredient(s) after administration.] |
| Coated Capsule Dosage Form | NCIT_C42895 | [A capsule that contains an additional outer layer over the capsule shell.] |
| Sprinkle Capsule Dosage Form | NCIT_C68946 | [A capsule composed active and/or inert ingredient(s) of as small pellet-like granules. The capsule is intended to be broken open, facilitating the scattering of the granules into soft foods, although it may also be swallowed whole.] |
| Sustained Release Pellet Capsule Dosage Form | NCIT_C68947 | [A capsule composed of active and/or inert ingredient(s) small, spherical structures that contain active and/or inert ingredient(s) encased within a shell. It is designed to release ingredients slowly so as to achieve a constant circulating concentration of the ingredient over a period of time.] |
| Implanted Fiducial-Based Imaging System | NCIT_C68948 | |
| Bar Dosage Form | NCIT_C68950 | [A solid or semi-solid in a singular unit that is rectangular or oval in shape.] |
| Cake Dosage Form | NCIT_C68951 | [A solid composed of active ingredient(s), excipients (usually electrolytes and bulking agents), and a solvent system which are lyophilized to yield a compressed solid with uniform ingredient distribution. The resulting lyophilized cake maintains its structure and stability over an extended period of time, and is intended for reconstitution prior to administration.] |
| ATP8A2 wt Allele | NCIT_C54333 | [Human ATP8A2 wild-type allele is located within 13q12-13 and is approximately 649 kb in length. This allele, which encodes probable phospholipid-transporting ATPase IB protein, plays a role in the binding and hydrolysis of ATP.] |
| ATP8A2 Gene | NCIT_C24247 | [This gene plays a role in cellular transport. It is purported to be involved in the modulation of amphipathic transporters and their activities.] |
| Laryngeal Basaloid Carcinoma | NCIT_C54334 | [An aggressive variant of squamous cell carcinoma that arises from the pyriform sinus or supraglottic area. It is characterized by the presence of small malignant cells with hyperchromatic nuclei and scant amount of cytoplasm forming lobules with peripheral palisading. Comedonecrosis may be present. An in situ or invasive keratinizing squamous cell carcinoma component is always present. Signs and symptoms include hoarseness, dysphagia, pain, and neck mass.] |